We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

April 15, 2021

CMS Interoperability and Synthetic Datasets

Events
Alette Brinth

When the CMS announced their interoperability ruling in 2019, payers came up against the challenge of how to make their member data interoperable and securely exchanged. In response Humana created the HDX (Humana Data Exchange), an API marketplace and synthetic data asset to serve as a centralized data interoperability and innovation hub. In addition to meeting the CMS compliance requirements, the HDX makes data interoperable for developers and end consumers. 

 

For years, the healthcare industry has been ripe with discussion about how healthcare consumers can be empowered to manage their own data. Earlier this year we started working with Humana to explore what it means for the end-consumer to have power over their own data and what it means for developers to have access to synthetic member datasets - here goes….

 

What is in the HDX?  The HDX is an end-to-end solution that contains two things: an API marketplace and a synthetic data Innovation Sandbox. The API marketplace gives members and developers access to APIs/FHIR standards for simplified data exchange, while the Innovation sandbox provides engineers/data-scientists access to synthetic data to test and learn in a secure environment.

 

What is in the API marketplace? There are 9 FHIR APIs currently available in the API marketplace, created through an iterative development process. The APIs cover the key categories including patient demographics, claims history, insurance/coverage information as well as a host of clinical assets, history of conditions and medications. 

 

What is the synthetic data environment? At a high level, this is a synthetic dataset of 500,000 lives broadly bucketed into demographics/coverage details, medical claims (providers/sites of care/diagnosis and procedure codes), pharmacy claims and lab tests/corresponding results. The synthetic data is completely anonymous but fully representative of a real data set. 

 

Why was the HDX created? In a nutshell, the HDX was created to give end-consumers (Humana members) power over their own healthcare data in a centralized location, making sure the data is accessible to be used by each member as, when and how they want.

 

How does the HDX benefit Humana members? For members, the APIs enable them to control their data and share it with any application that has connected with their portal to achieve their best health through seamless data exchange. The FHIR APIs will help Humana plan members understand which providers are in-network and what is covered by their plan.  

 

How does the HDX benefit developers? For developers the HDX is a fast track way to engage with Humana data in an easy, secure manner before establishing any formal partnerships. 

 

The healthcare industry needs to be able to access and analyze data to achieve better patient engagement, improve the patient journey and give stakeholders access to information in real time for better health outcomes. 

 

The HDX sets a new bar for data access and interoperability and can be accessed HERE.

 

For more on the topic our recent blog explores how data can be used to best serve patients and drive innovative outcomes. 

 

Anything you need to know? We’d love to hear from you

 

Couldn’t make it? You can see the full webinar below.


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Pharmacies in the US as a Distribution Model for DTx

30th March @ 10:45 AM EDT

The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.

Featuring
Mark Thomas
Mark Thomas
Healthcare Consultant, ProspHire
Featuring
Mark Thomas
Mark Thomas
Healthcare Consultant, ProspHire
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Understanding the Burden of Digital Health Compliance: Regulations, Security & Privacy

13th April 2023 @ 10:45AM EDT

Are your Digital Health innovations being slowed or even derailed by regulatory, security, privacy or legal compliance considerations? Apply now to join HealthXL in this expert led Masterclass to deep dive into this topic.

Featuring
Randy Horton
Randy Horton
VP of Solutions and Partnerships, Orthogonal
Featuring
Randy Horton
Randy Horton
VP of Solutions and Partnerships, Orthogonal
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How Can DTx Companies Enter the US Market Successfully?

27th April 2023 @ 10:45 AM EDT

Despite the rapid expansion of the digital therapeutics (DTx) market in the US, DTx companies are still facing challenges in establishing a foothold and making an impact in the digital health industry. Join this masterclass with Jonas Duss (Co-Founder at Kaia Health) to discuss the key challenges facing DTx companies seeking to enter the US market. Seats are limited so apply now to secure your place.

Featuring
Jonas Duss
Jonas Duss
Co-Founder, Kaia Health
Featuring
Jonas Duss
Jonas Duss
Co-Founder, Kaia Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: When and how should your digital health solution be regulated?

11th May @ 10:45AM EDT

Do you need guidance on the best practices for gaining regulatory approval for your digital health solution? Then this masterclass is the perfect fit for you! Apply now to secure your place.

Featuring
Acacia Parks
Acacia Parks
Lead Consultant and Founder, Liquid Amber Consulting
Featuring
Acacia Parks
Acacia Parks
Lead Consultant and Founder, Liquid Amber Consulting

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
28th March 2023 @ 10:45AM EDT

Masterclass: Current State of Routes to Market in Digital Health

Digital health solutions can be commercialized in various ways depending on factors such as value proposition, stakeholders, and regulatory requirements. Join this expert led Masterclass to dive deeper into this topic.

Maurice Solomon
Featuring
Maurice Solomon
Principal, ZS
Clinical Trials Innovation
29th March 2023 @ 10:45AM EDT

Masterclass: Design and Control Conditions for Clinical Trials of Digital Health Solutions

Clinical efficacy is a crucial factor for the commercial success of Digital Health solutions. Apply now to join HealthXL in this session as we deep dive into this topic.

David Hohenschurz-Schmidt
Featuring
David Hohenschurz-Schmidt
Postgraduate Researcher, Imperial College London
Digital Therapeutics (DTx)
30th March @ 10:45 AM EDT

Pharmacies in the US as a Distribution Model for DTx

The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.

Mark Thomas
Featuring
Mark Thomas
Healthcare Consultant, ProspHire
Clinical Trials Innovation
4th April 2023 @ 10:45 AM EDT

Masterclass: Operations Considerations for Designing Clinical Trials for Digital Health Solutions

Conducting RCTs is a significant undertaking that requires substantial investments and financial resources. Apply now to join your peers in this expert led Masterclass.

Jessica Lake, PhD
Featuring
Jessica Lake, PhD
Chief Science Officer, Limbix

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.